Surgical Science Sweden AB (publ) (SUS.ST)

SEK 154.5

(0.85%)

Long Term Debt Summary of Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ)'s latest annual long term debt in 2023 was 40.02 Million SEK , up 172.6% from previous year.
Surgical Science Sweden AB (publ)'s latest quarterly long term debt in 2024 Q2 was - SEK , down 0.0% from previous quarter.
Surgical Science Sweden AB (publ) reported annual long term debt of 14.68 Million SEK in 2022, up 21.63% from previous year.
Surgical Science Sweden AB (publ) reported annual long term debt of 12.07 Million SEK in 2021, up 420.3% from previous year.
Surgical Science Sweden AB (publ) reported quarterly long term debt of - SEK for 2024 Q1, down 0.0% from previous quarter.
Surgical Science Sweden AB (publ) reported quarterly long term debt of 40.02 Million SEK for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Surgical Science Sweden AB (publ) (2023 - 2014)

Historical Annual Long Term Debt of Surgical Science Sweden AB (publ) (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	40.02 Million SEK	172.6%
2022	14.68 Million SEK	21.63%
2021	12.07 Million SEK	420.3%
2020	2.32 Million SEK	3.25%
2019	2.24 Million SEK	-48.6%
2018	4.37 Million SEK	58.41%
2017	2.76 Million SEK	-85.55%
2016	19.1 Million SEK	-11.57%
2015	21.6 Million SEK	0.0%
2014	- SEK	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- SEK	0.0%
2024 Q1	- SEK	0.0%
2023 Q4	40.02 Million SEK	0.0%
2023 FY	40.02 Million SEK	172.6%
2023 Q1	- SEK	-100.0%
2023 Q2	- SEK	0.0%
2023 Q3	- SEK	0.0%
2022 Q2	- SEK	0.0%
2022 Q4	14.68 Million SEK	0.0%
2022 Q3	- SEK	0.0%
2022 Q1	- SEK	-100.0%
2022 FY	14.68 Million SEK	21.63%
2021 Q2	- SEK	0.0%
2021 Q3	- SEK	0.0%
2021 FY	12.07 Million SEK	420.3%
2021 Q4	12.07 Million SEK	0.0%
2021 Q1	- SEK	-100.0%
2020 Q2	- SEK	0.0%
2020 FY	2.32 Million SEK	3.25%
2020 Q3	- SEK	0.0%
2020 Q4	2.32 Million SEK	0.0%
2020 Q1	- SEK	-100.0%
2019 Q2	- SEK	-100.0%
2019 FY	2.24 Million SEK	-48.6%
2019 Q4	2.24 Million SEK	-87.24%
2019 Q3	17.6 Million SEK	0.0%
2019 Q1	4.99 Million SEK	14.27%
2018 Q4	4.37 Million SEK	82.17%
2018 FY	4.37 Million SEK	58.41%
2018 Q1	2.5 Million SEK	-9.42%
2018 Q2	2.5 Million SEK	0.0%
2018 Q3	2.4 Million SEK	-4.0%
2017 Q1	19.1 Million SEK	0.0%
2017 Q2	- SEK	-100.0%
2017 FY	2.76 Million SEK	-85.55%
2017 Q3	2.9 Million SEK	0.0%
2017 Q4	2.76 Million SEK	-4.83%
2016 FY	19.1 Million SEK	-11.57%
2016 Q1	- SEK	0.0%
2016 Q4	19.1 Million SEK	0.0%
2015 FY	21.6 Million SEK	0.0%
2014 FY	- SEK	0.0%

Peer Long Term Debt Comparison of Surgical Science Sweden AB (publ)

Name	Long Term Debt	Long Term Debt Difference
Aino Health AB (publ)	164 Thousand SEK	-24304.268%
Bonzun AB (publ)	554 Thousand SEK	-7124.368%
Kontigo Care AB (publ)	3.67 Million SEK	-989.061%
Medhelp Care Aktiebolag (publ)	- SEK	-Infinity%
RaySearch Laboratories AB (publ)	431.97 Million SEK	90.735%